Fingerprint
Dive into the research topics of 'Targeting the gatekeeper: Osimertinib in EGFR T790M mutation-positive non-small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Targeting the gatekeeper: Osimertinib in EGFR T790M mutation-positive non-small cell lung cancer
Ferdinandos Skoulidis, Vassiliki A. Papadimitrakopoulou
Research output: Contribution to journal › Review article › peer-review
36
Scopus
citations